| pubmed-article:17623613 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17623613 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:17623613 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:17623613 | lifeskim:mentions | umls-concept:C0007115 | lld:lifeskim |
| pubmed-article:17623613 | lifeskim:mentions | umls-concept:C0242382 | lld:lifeskim |
| pubmed-article:17623613 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:17623613 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17623613 | pubmed:dateCreated | 2007-7-11 | lld:pubmed |
| pubmed-article:17623613 | pubmed:abstractText | The preoperative evaluation of the clinically N0 neck and the operative management of cervical lymph nodes in patients with papillary and medullary thyroid cancer remains controversial. The appreciation that even patients with low-risk disease have a significant risk for recurrence has generated interest in a more comprehensive preoperative evaluation of the neck and has renewed debate on the extent of lymphadenectomy at the time of thyroidectomy. The authors recommend using preoperative ultrasound before thyroidectomy for all patients with thyroid cancer and before any subsequent surgeries for recurrent disease to identify the extent of lymph node metastases and thereby facilitate complete surgical removal of all gross disease in the neck. The optimal surgical procedure for removing cervical lymphadenopathy is compartment-oriented neck dissection based on the findings from preoperative ultrasound. | lld:pubmed |
| pubmed-article:17623613 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17623613 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17623613 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17623613 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17623613 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17623613 | pubmed:issn | 1540-1405 | lld:pubmed |
| pubmed-article:17623613 | pubmed:author | pubmed-author:EvansDouglas... | lld:pubmed |
| pubmed-article:17623613 | pubmed:author | pubmed-author:GrubbsElizabe... | lld:pubmed |
| pubmed-article:17623613 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17623613 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:17623613 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17623613 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17623613 | pubmed:pagination | 623-30 | lld:pubmed |
| pubmed-article:17623613 | pubmed:meshHeading | pubmed-meshheading:17623613... | lld:pubmed |
| pubmed-article:17623613 | pubmed:meshHeading | pubmed-meshheading:17623613... | lld:pubmed |
| pubmed-article:17623613 | pubmed:meshHeading | pubmed-meshheading:17623613... | lld:pubmed |
| pubmed-article:17623613 | pubmed:meshHeading | pubmed-meshheading:17623613... | lld:pubmed |
| pubmed-article:17623613 | pubmed:meshHeading | pubmed-meshheading:17623613... | lld:pubmed |
| pubmed-article:17623613 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17623613 | pubmed:articleTitle | Role of lymph node dissection in primary surgery for thyroid cancer. | lld:pubmed |
| pubmed-article:17623613 | pubmed:affiliation | Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-1402, USA. | lld:pubmed |
| pubmed-article:17623613 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17623613 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:17623613 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17623613 | lld:pubmed |
